Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and 5-MeO-DiPT: Difference between pages
Appearance
(Difference between pages)
Content deleted Content added
Saving copy of the {{drugbox}} taken from revid 473946899 of page 5-Methoxy-diisopropyltryptamine for the Chem/Drugbox validation project (updated: 'CAS_number'). |
|||
Line 1: | Line 1: | ||
{{Short description|Psychedelic tryptamine}} |
|||
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:5-Methoxy-diisopropyltryptamine|oldid=473946899}} 473946899] of page [[5-Methoxy-diisopropyltryptamine]] with values updated to verified values.}} |
|||
{{Drugbox |
{{Drugbox |
||
| drug_name = 5-Methoxy-''N'',''N''-diisopropyltryptamine |
|||
⚫ | |||
| Verifiedfields = changed |
|||
| Watchedfields = changed |
|||
⚫ | |||
| IUPAC_name = 3-[2-(Diisopropylamino)ethyl]-5-methoxyindole |
| IUPAC_name = 3-[2-(Diisopropylamino)ethyl]-5-methoxyindole |
||
| image = 5-MeO-DiPT.svg |
| image = 5-MeO-DiPT.svg |
||
Line 8: | Line 11: | ||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = |
||
| legal_BR = F2 |
|||
| legal_BR_comment = <ref>{{Cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=2023-07-24 |title=RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451 |url-status=live |archive-url=https://web.archive.org/web/20230827163149/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451 |archive-date=2023-08-27 |access-date=2023-08-27 |publisher=[[Diário Oficial da União]] |language=pt-BR |publication-date=2023-07-25}}</ref> |
|||
| legal_UK = Class A |
| legal_UK = Class A |
||
| legal_US = Schedule I |
| legal_US = Schedule I |
||
| legal_DE = Anlage I, In general |
|||
| legal_status = |
|||
/ Unscheduled unless that it was for human consumption. |
|||
/ Illegal in Sweden, Denmark, Greece, Japan, Singapore and China. |
|||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
| excretion = |
| excretion = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite| |
| CAS_number_Ref = {{cascite|changed|CAS}} |
||
| CAS_number = |
| CAS_number = 4021-34-5 |
||
| PubChem = 151182 |
| PubChem = 151182 |
||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
||
| DrugBank = DB01441 |
| DrugBank = DB01441 |
||
| KEGG_Ref = {{keggcite|correct|kegg}} |
|||
| KEGG = C22724 |
|||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = 133247 |
| ChemSpiderID = 133247 |
||
| ChEBI_Ref = {{ebicite|correct|EBI}} |
| ChEBI_Ref = {{ebicite|correct|EBI}} |
||
| ChEBI = 48282 |
| ChEBI = 48282 |
||
| UNII_Ref = {{fdacite|changed|FDA}} |
|||
| UNII = 12D06G8W8E |
|||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=17 | H=26 | N=2 | O=1 |
| C=17 | H=26 | N=2 | O=1 |
||
| smiles = CC(C)N(C(C)C)CCC1=C[NH]C(C=C2)=C1C=C2OC |
|||
| molecular_weight = 274.4 |
|||
| smiles = O(c1cc2c(cc1)ncc2CCN(C(C)C)C(C)C)C |
|||
| InChI = 1/C17H26N2O/c1-12(2)19(13(3)4)9-8-14-11-18-17-7-6-15(20-5)10-16(14)17/h6-7,10-13,18H,8-9H2,1-5H3 |
|||
| InChIKey = DNBPMBJFRRVTSJ-UHFFFAOYAF |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C17H26N2O/c1-12(2)19(13(3)4)9-8-14-11-18-17-7-6-15(20-5)10-16(14)17/h6-7,10-13,18H,8-9H2,1-5H3 |
| StdInChI = 1S/C17H26N2O/c1-12(2)19(13(3)4)9-8-14-11-18-17-7-6-15(20-5)10-16(14)17/h6-7,10-13,18H,8-9H2,1-5H3 |
||
Line 39: | Line 46: | ||
| melting_point = 181 |
| melting_point = 181 |
||
}} |
}} |
||
[[Image:5meodipt.jpg|thumb|right|5-MeO-DiPT tablets from [[Salem, Oregon|Salem]], [[Oregon]]]] |
|||
'''5-Methoxy-''N'',''N''-diisopropyltryptamine''' ('''5-MeO-DiPT''', sometimes called '''foxy methoxy''' or simply '''foxy'''<ref>{{cite journal | vauthors = Narimatsu S, Yonemoto R, Saito K, Takaya K, Kumamoto T, Ishikawa T, Asanuma M, Funada M, Kiryu K, Naito S, Yoshida Y, Yamamoto S, Hanioka N | display-authors = 6 | title = Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes | journal = Biochemical Pharmacology | volume = 71 | issue = 9 | pages = 1377–1385 | date = April 2006 | pmid = 16510126 | doi = 10.1016/j.bcp.2006.01.015 }}</ref>) is a [[psychedelic drug|psychedelic]] tryptamine and the [[methoxy group|methoxy]] [[derivative (chemistry)|derivative]] of [[diisopropyltryptamine]] (DiPT). |
|||
==Pharmacology== |
|||
The mechanism that produces the purported hallucinogenic and entheogenic effects of 5-MeO-DiPT is thought to result primarily from [[5-HT2A receptor|5-HT<sub>2A</sub> receptor]] [[agonist|agonism]], although additional mechanisms of action such as [[monoamine oxidase inhibitor|monoamine oxidase inhibition]] (MAOI) may be involved also.<ref name="pmid17223101">{{cite journal | vauthors = Nagai F, Nonaka R, Satoh Hisashi Kamimura K | title = The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain | journal = European Journal of Pharmacology | volume = 559 | issue = 2–3 | pages = 132–137 | date = March 2007 | pmid = 17223101 | doi = 10.1016/j.ejphar.2006.11.075 }}</ref> The strongest receptor binding affinity for 5-MeO-DiPT is at the [[5-HT1A receptor|5-HT<sub>1A</sub> receptor]].<ref>{{cite journal | vauthors = Ray TS | title = Psychedelics and the human receptorome | journal = PLOS ONE | volume = 5 | issue = 2 | pages = e9019 | date = February 2010 | pmid = 20126400 | pmc = 2814854 | doi = 10.1371/journal.pone.0009019 | doi-access = free | bibcode = 2010PLoSO...5.9019R }}</ref> |
|||
5-MeO-DiPT is [[Neurotoxin|neurotoxic]] in rats.<ref>{{cite journal | vauthors = Noworyta-Sokołowska K, Kamińska K, Kreiner G, Rogóż Z, Gołembiowska K | title = Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats | journal = Neurotoxicity Research | volume = 30 | issue = 4 | pages = 606–619 | date = November 2016 | pmid = 27461536 | pmc = 5047954 | doi = 10.1007/s12640-016-9654-0 }}</ref> |
|||
==Overdose== |
|||
Excessive doses have caused clinical intoxication, characterized by nausea, vomiting, agitation, hypotension, mydriasis, tachycardia and hallucinations, in a number of young adults. A number of these overdoses are attributed to the drug’s extended onset of action, where first time users, who were unfamiliar with the drug, administered a second dose after initially feeling no effects. [[Rhabdomyolysis]] and renal failure occurred in one young man and another one died 3–4 hours after an apparent rectal overdose.<ref>{{cite book | vauthors = Baselt R | title = Disposition of Toxic Drugs and Chemicals in Man | edition = 8th | publisher = Biomedical Publications | location = Foster City, CA | date = 2008 | pages = 975–976}}</ref> At least one death has been attributed to consumption of 5-MeO-DiPT.<ref>{{cite journal | vauthors = Tanaka E, Kamata T, Katagi M, Tsuchihashi H, Honda K | title = A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy | journal = Forensic Science International | volume = 163 | issue = 1–2 | pages = 152–154 | date = November 2006 | pmid = 16406422 | doi = 10.1016/j.forsciint.2005.11.026 }}</ref> |
|||
==Drug prohibition laws== |
|||
{{More citations needed|section|date=June 2019|small=y}} |
|||
===China=== |
|||
As of October 2015 5-MeO-DiPT is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=zh | access-date=1 October 2015 | archive-url=https://web.archive.org/web/20151001222554/http://www.sfda.gov.cn/WS01/CL0056/130753.html | archive-date=1 October 2015 | url-status=dead }}</ref> |
|||
===Denmark=== |
|||
Illegal since February 2004. |
|||
===Germany=== |
|||
Illegal since September 1999. |
|||
===Greece=== |
|||
Illegal since February 2003. |
|||
===Japan=== |
|||
Illegal since April 2005. |
|||
===Singapore=== |
|||
Illegal since early 2006. |
|||
===Sweden=== |
|||
[[Riksdag|''Sveriges riksdags'']] health ministry [[:sv:Statens folkhälsoinstitut|''Statens folkhälsoinstitut'']] classified 5-MeO-DiPT as "health hazard" under the act [[:sv:Lagen om förbud mot vissa hälsofarliga varor|''Lagen om förbud mot vissa hälsofarliga varor'']] (translated ''Act on the Prohibition of Certain Goods Dangerous to Health'') as of Oct 1, 2004, in their regulation '''SFS 2004:696''' listed as '''5-metoxi-N,N-diisopropyltryptamin (5-MeO-DIPT)''', making it illegal to sell or possess.<ref>{{cite web |url=http://www.notisum.se/rnp/sls/sfs/20040696.pdf |title=notisum.se |access-date=2013-09-06 |url-status=live |archive-url=https://web.archive.org/web/20130929063316/http://www.notisum.se/rnp/sls/sfs/20040696.pdf |archive-date=2013-09-29 }}</ref> |
|||
===United States=== |
|||
On April 4, 2003, the [[United States]] [[Drug Enforcement Administration|DEA]] added both 5-MeO-DiPT and [[Alpha-Methyltryptamine|alpha-methyltryptamine]] (AMT) to Schedule I of the [[Controlled Substances Act]] under "emergency scheduling" procedures. The drugs were officially placed into Schedule I on September 29, 2004. Prior to its prohibition in the U.S., 5-MeO-DiPT was sold online alongside psychoactive analogues such as [[Diisopropyltryptamine|DiPT]], and [[Dipropyltryptamine|DPT]], neither of which have yet been expressly outlawed. |
|||
== See also == |
|||
* [[5-MeO-DiBF]] |
|||
* [[5-MeO-DMT]] |
|||
* [[5-MeO-DPT]] |
|||
* [[5-MeO-AMT]] |
|||
* [[5-MeO-MiPT]] |
|||
* [[Dimethyltryptamine|DMT]] |
|||
* [[Dipropyltryptamine|DPT]] |
|||
* [[Alphamethyltryptamine|AMT]] |
|||
* [[Diisopropyltryptamine|DIPT]] |
|||
* [[N-Methyl-N-isopropyltryptamine|MIPT]] |
|||
== References == |
|||
{{Reflist}} |
|||
== External links == |
|||
* [http://www.deadiversion.usdoj.gov/fed_regs/rules/2004/fr0929.htm Official Ruling Placing 5-MeO-DIPT into Schedule I] |
|||
* [http://www.erowid.org/chemicals/5meo_dipt/5meo_dipt.shtml Erowid information on 5-MeO-DIPT]. |
|||
* [https://isomerdesign.com/PiHKAL/read.php?domain=tk&id=37 5-MeO-DIPT entry in TiHKAL • info] |
|||
{{Hallucinogenic tryptamines}} |
|||
{{Serotonin receptor modulators}} |
|||
{{Sigma receptor modulators}} |
|||
{{Tryptamines}} |
|||
{{DEFAULTSORT:Methoxy-N N-diisopropyltryptamine 5-}} |
|||
[[Category:Designer drugs]] |
|||
[[Category:Phenol ethers]] |
|||
[[Category:Psychedelic tryptamines]] |
|||
[[Category:Serotonin receptor agonists]] |
|||
[[Category:Neurotoxins]] |
|||
[[Category:Diisopropylamino compounds]] |
|||
[[Category:Methoxy compounds]] |